4
Changes in Ownership
Caribou Biosciences, Inc. Filed Acc 0001209191-22-016872
Chief Scientific Officer acquired 10,720 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kanner Steven Chief Scientific Officer | 2022-03-04 | Option exercise | +9,171 | $2.69 | $24,670 | 226,090 | D: show line 1 in the form |
| Kanner Steven Chief Scientific Officer | 2022-03-04 | Option exercise | +1,549 | $4.11 | $6,366 | 227,639 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kanner Steven Chief Scientific Officer | 2022-03-04 | Option exercise · Option to purchase Common Stock | −9,171 | 122,963 | D: show line 3 in the form | |||||
| Kanner Steven Chief Scientific Officer | 2022-03-04 | Option exercise · Option to purchase Common Stock | −1,549 | 230,365 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…